What is the correct dosage and administration (SIG) of Bromfed DM (brompheniramine maleate and dextromethorphan) for a 4‑year‑old child weighing 16.4 kg with a viral urinary infection and cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Prescribe Bromfed DM to This Child

I strongly recommend against prescribing Bromfed DM (or any cough/cold medication containing dextromethorphan, brompheniramine, or pseudoephedrine) to a 4-year-old child with a viral upper respiratory infection (URI) and cough. These medications lack proven efficacy in children and carry risks of adverse effects.

Key Evidence Against Use

Lack of Efficacy in Pediatric Viral URI

The American Academy of Pediatrics explicitly states that codeine- and dextromethorphan-containing cough remedies lack proven antitussive effects in children and recommends educating parents about the potential risks of these products 1. The ACCP guidelines on cough suppressants note that peripheral and central cough suppressants have limited efficacy for cough due to URI and are not recommended for this indication 2.

Safety Concerns

The FDA drug label for Bromfed DM does not provide specific pediatric dosing for children under 6 years of age 3. The overdose data is particularly concerning: seizures have been reported in children following ingestion of only 13-17 mg/kg of dextromethorphan, and the toxic response can be unpredictable even with small amounts 3, 4.

Why This Matters for Your Patient

  • Age: At 4 years old, this child falls below the typical safety threshold for these combination products
  • Diagnosis: Viral URI with cough is self-limited and does not require pharmacologic suppression
  • Risk-Benefit: No proven benefit with documented risks of CNS effects, anticholinergic effects, and potential toxicity

What to Do Instead

Provide supportive care and parent education:

  • Reassure parents that viral URI cough is self-limited (typically 1-2 weeks)
  • Recommend adequate hydration
  • Consider honey (if >1 year old) for symptomatic relief
  • Advise on warning signs requiring re-evaluation (respiratory distress, high fever, dehydration)

Common Pitfall to Avoid

Do not yield to parental pressure for "something to give" when the evidence shows these medications are ineffective and potentially harmful in young children. The appropriate prescription here is no prescription – focus on education and expectant management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.